Literature DB >> 8976646

Serum soluble interleukin-2 receptor levels in familial Mediterranean fever.

E Erken1, R Güneşaçar, S Ozbek, K Konca.   

Abstract

OBJECTIVE: To investigate serum soluble interleukin-2 receptor (sIL-2R) in familial Mediterranean fever (FMF) and assess its role in acute FMF crisis.
METHODS: Serum sIL-2R concentrations were measured in patients with FMF during acute crises and during inactive periods of the disease, using an immunoenzymatic assay kit. Twenty four FMF patients during acute crisis (active FMF), 17 patients with inactive FMF, 24 healthy controls, and 20 active patients with rheumatoid arthritis (as a disease control group) were studied.
RESULTS: Serum sIL-2R concentrations were increased during an acute FMF crisis compared with the values in inactive FMF patients and healthy controls (P = 0.0105 and P = 0.0012 respectively), while there was no significant difference between the mean values in active FMF and rheumatoid arthritis patients (P = 0.7325). In 14 of the FMF group whose blood samples were available in both active and inactive phases, sIL-2R concentrations were significantly higher in an acute attack than in an attack-free period (P = 0.027).
CONCLUSIONS: An increase in sIL-2R may be a result of hyperreactivity of IL-2R-expressing cells during an acute inflammatory attack of FMF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8976646      PMCID: PMC1010325          DOI: 10.1136/ard.55.11.852

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

1.  Decreased interleukin 1 activity released from circulating monocytes of patients with familial Mediterranean fever during in vitro stimulation by lipopolysaccharide.

Authors:  M Rozenbaum; R Katz; I Rozner; S Pollack
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

2.  Serum amyloid A protein in familial Mediterranean fever.

Authors:  A Knecht; F C de Beer; M Pras
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

3.  Immunoregulatory abnormalities in familial Mediterranean fever.

Authors:  D Ilfeld; S Weil; O Kuperman
Journal:  Clin Immunol Immunopathol       Date:  1981-02

4.  Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean fever.

Authors:  Y Matzner; R E Partridge; M Levy; B M Babior
Journal:  Blood       Date:  1984-03       Impact factor: 22.113

5.  C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever.

Authors:  Y Matzner; A Brzezinski
Journal:  N Engl J Med       Date:  1984-08-02       Impact factor: 91.245

6.  Tumor necrosis factor in familial Mediterranean fever.

Authors:  A Schattner; M Lachmi; A Livneh; M Pras; T Hahn
Journal:  Am J Med       Date:  1991-04       Impact factor: 4.965

7.  Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis.

Authors:  E C Keystone; K M Snow; C Bombardier; C H Chang; D L Nelson; L A Rubin
Journal:  Arthritis Rheum       Date:  1988-07

8.  Soluble interleukin-2 receptors in systemic lupus erythematosus.

Authors:  R E Wolf; W G Brelsford
Journal:  Arthritis Rheum       Date:  1988-06

9.  Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis.

Authors:  T Matsumoto; K Iwasaki
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

10.  The immune regulation in familial Mediterranean fever (FMF).

Authors:  A Melamed; S Cabili; V Zakuth; Z Spirer
Journal:  J Clin Lab Immunol       Date:  1988-07
View more
  7 in total

1.  Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever.

Authors:  Eren Erken; Huseyin T E Ozer; Ramazan Gunesacar
Journal:  Rheumatol Int       Date:  2006-01-06       Impact factor: 2.631

2.  Bone mineral density in patients with familial Mediterranean fever.

Authors:  Kadir Yildirim; Saliha Karatay; Ramazan Cetinkaya; Hulya Uzkeser; Akin Erdal; Ilyas Capoglu; Fazile Hatipoglu Erdem
Journal:  Rheumatol Int       Date:  2009-05-16       Impact factor: 2.631

3.  Continuity of cytokine activation in patients with familial Mediterranean fever.

Authors:  Sait Bagci; Bulent Toy; Ahmet Tuzun; Yuksel Ates; Murat Aslan; Ali Inal; Mustafa Gulsen; Necmettin Karaeren; Kemal Dagalp
Journal:  Clin Rheumatol       Date:  2004-05-01       Impact factor: 2.980

4.  Evaluation of IL-1β, IL-1ra, and IL-10 levels and outcome of periodontal therapy in chronic periodontitis with familial Mediterranean fever.

Authors:  Vildan Bostanci; Hulya Toker; Soner Senel; Omer Poyraz; Aysun Akpinar; Emine Pirim Görgün; Olcay Bakar
Journal:  Clin Oral Investig       Date:  2016-04-11       Impact factor: 3.573

5.  Does immune activation continue during an attack-free period in familial Mediterranean fever?

Authors:  U Musabak; A Sengul; C Oktenli; S Pay; Z Yesilova; L Kenar; S Y Sanisoglu; A Inal; A Tuzun; A Erdil; S Bagci
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

6.  Tumor necrosis factor-alpha gene promoter polymorphism in patients with familial Mediterranean fever.

Authors:  Arzu Celebi Kobak; Senol Kobak; Yasemin Kabasakal; Ulus Salih Akarca
Journal:  Clin Rheumatol       Date:  2006-10-21       Impact factor: 3.650

7.  Relationship between serum interleukin-1beta levels and acute phase response proteins in patients with familial Mediterranean fever.

Authors:  Kadir Yildirim; Hulya Uzkeser; Mustafa Keles; Saliha Karatay; Ahmet Kiziltunc; Muhammet Dursun Kaya; Abdulkadir Yildirim
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.